APA (7th ed.) Citation

T, M., CR, S., A, B., L, P., N, P., B, N., & KJL, B. (2023). Should low-risk DCIS lose the cancer label? An evidence review. Breast cancer research and treatment, 199(3), 415. https://doi.org/10.1007/s10549-023-06934-y

Chicago Style (17th ed.) Citation

T, Ma, Semsarian CR, Barratt A, Parker L, Pathmanathan N, Nickel B, and Bell KJL. "Should Low-risk DCIS Lose the Cancer Label? An Evidence Review." Breast Cancer Research and Treatment 199, no. 3 (2023): 415. https://doi.org/10.1007/s10549-023-06934-y.

MLA (9th ed.) Citation

T, Ma, et al. "Should Low-risk DCIS Lose the Cancer Label? An Evidence Review." Breast Cancer Research and Treatment, vol. 199, no. 3, 2023, p. 415, https://doi.org/10.1007/s10549-023-06934-y.